Cargando…
Zyxin protects from hypertension-induced cardiac dysfunction
Arterial hypertension causes left ventricular hypertrophy leading to dilated cardiomyopathy. Following compensatory cardiomyocyte hypertrophy, cardiac dysfunction develops due to loss of cardiomyocytes preceded or paralleled by cardiac fibrosis. Zyxin acts as a mechanotransducer in vascular cells th...
Autores principales: | Al-Hasani, Jaafar, Sens-Albert, Carla, Ghosh, Subhajit, Trogisch, Felix A., Nahar, Taslima, Friede, Prisca A. P., Reil, Jan-Christian, Hecker, Markus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786748/ https://www.ncbi.nlm.nih.gov/pubmed/35075545 http://dx.doi.org/10.1007/s00018-022-04133-4 |
Ejemplares similares
-
Characterisation of Lipoma-Preferred Partner as a Novel Mechanotransducer in Vascular Smooth Muscle Cells
por: Sporkova, Alexandra, et al.
Publicado: (2023) -
Loss of the Mechanotransducer Zyxin Promotes a Synthetic Phenotype of Vascular Smooth Muscle Cells
por: Ghosh, Subhajit, et al.
Publicado: (2015) -
Lin11-Isl1-Mec3 Domain Proteins as Mechanotransducers in Endothelial and Vascular Smooth Muscle Cells
por: Sporkova, Alexandra, et al.
Publicado: (2021) -
Zyxin-VASP interactions alter actin regulatory activity in zyxin-VASP complexes
por: Grange, Jacob, et al.
Publicado: (2012) -
The role of zyxin in regulation of malignancies
por: Kotb, Ahmed, et al.
Publicado: (2018)